![Isabelle de Baillenx](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Isabelle de Baillenx
Chief Executive Officer at FA Dièse SAS
Isabelle de Baillenx active positions
Companies | Position | Start | End |
---|---|---|---|
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | Chief Executive Officer | 23/07/2001 | - |
President | 10/04/2009 | - | |
Director of Investments | 23/07/2001 | 10/03/2010 | |
Flash Therapeutics SAS
![]() Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Director/Board Member | - | - |
Career history of Isabelle de Baillenx
Statistics
International
France | 3 |
Operational
Chief Executive Officer | 1 |
Director of Investments | 1 |
President | 1 |
Sectoral
Finance | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
FA Dièse SAS
![]() FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | Finance |
Flash Therapeutics SAS
![]() Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Commercial Services |
- Stock Market
- Insiders
- Isabelle de Baillenx
- Experience